CLSA Downgrades Bristol-Myers Squibb Co. (BMY) to Underperform
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $66.15 +2.35%
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Rating Summary:
12 Buy, 22 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 13 | New: 26
Join SI Premium – FREE
CLSA downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Outperform to Underperform, price target upped $2 to $35.00.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.62 yesterday.
For more ratings news on Bristol-Myers Squibb Co. click here and for the rating history of Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $32.62 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Reiterates Buy Rating on Bristol-Myers Squibb Co. (BMY)
- BNP Paribas Exane Downgrades Lanxess AG (LXS:GR) (LNXSF) to Underperform
- Macquarie Downgrades First Resources (FR:SP) to Neutral
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
